No, a meaningful/sustainable rise in the share price is achieved benchmarks up to the trials, other exciting platforms in the pipeline including any running con-currently, corporate advancements JV/partner negotiation etc, laboratory benchmarks achieved and views of current modellings etc etc. All helps to engage investors interested in diverging their portfolio away from commodities. Like myself.
If you are talking about a re-rate then yes successfully phase 1 trial moving onto stage 2.
I disagree with Ian Ross.
NRT Price at posting:
13.0¢ Sentiment: Hold Disclosure: Held